DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread
Conditions: Adenocarcinoma Gastric Stage IV With Metastases; Adenocarcinoma - GEJ Intervention: Drug: Trastuzumab deruxtecan Sponsor: Daiichi Sankyo, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Research